Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT00932256
Eligibility Criteria:
Inclusion Criteria:
* Males and females of any ethnic group between the ages of 18 and 60 years of age.
* History of moderate to severe SAR for at least one year.
* Subjects' symptoms will include the five symptoms ("S5") that are the focus of this study:
* nasal congestion;
* rhinorrhea;
* nasal itching;
* sneezing;
* post nasal drip.
* Prior to study subjects' good health will be confirmed by medical history and physical examination.
* Allergic hypersensitivity will be confirmed by an appropriate test as deemed necessary by the physician or well established medical history.
Exclusion Criteria:
* Pregnancy or lactation.
* Immunotherapy unless at stable maintenance dose.
* Presence of a medical condition that might interfere with treatment evaluation or require a change in therapy including but not limited to high blood pressure or urinary retention problems.
* Alcohol dependence.
* Use of any other investigational drug in the previous month.
* Subjects presenting with asthma requiring corticosteroid treatment.
* Subjects with multiple drug allergies.
* Subjects known to have an idiosyncratic reaction to any of the ingredients in STAHIST.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00932256
Study Brief:
Protocol Section:
NCT00932256